Case number 1:22-cv-01124
Neurocrine Biosciences, Inc. v. Sandoz Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 22, 2022 | 11 | ANSWER to 1 Complaint, , COUNTERCLAIM against Neurocrine Biosciences, Inc. by Crystal Pharmatech Co., Ltd., Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd..(Golden, Ronald) (Entered: 11/22/2022) (25) |
| Nov 10, 2022 | 10 | STIPULATION Seeking to Extend the Deadline by Which the Parties in the Non-Consolidated Cases Must Inform the Court Whether they Agree to be Consolidated With, and Adopt the Schedule of the Lead Case, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 11/10/2022) (5) |
| Oct 19, 2022 | 9 | ORAL ORDER RESETTING Teleconference - IT IS HEREBY ORDERED that the 10/24/2022 teleconference is RESET for 11/3/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/19/2022. (dlw) (Entered: 10/19/2022) (0) |
| Oct 13, 2022 | 8 | SO ORDERED re (7 in 1:22-cv-01124-MN) (62 in 1:21-cv-01042-MN) Stipulation as to Joinder and Dismissal of Certain Parties and Order. Signed by Judge Maryellen Noreika on 10/13/2022. (dlw) (Entered: 10/13/2022) (7) |
| Oct 12, 2022 | 7 | STIPULATION as to Joinder and Dismissal of Certain Parties and [Proposed] Order by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz AG, Sandoz Inc., Sandoz International GmbH. (dlw) (Entered: 10/13/2022) (7) |
| Oct 6, 2022 | 6 | ORAL ORDER Setting Teleconference: IT IS HEREBY ORDERED that a Telephone Conference is set for 10/24/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/6/2022. (dlw) (Entered: 10/06/2022) (0) |
| Aug 26, 2022 | 1 | Complaint* (1) |
| Aug 26, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) (Entered: 08/29/2022) (3) |
| Aug 26, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/15/2022. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 10/11/2024. (lam) (Entered: 08/29/2022) (2) |
| Aug 26, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,039,627 ;8,357,697 ;11,311,532. (lam) (Entered: 08/29/2022) (1) |
| Aug 26, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc.. (lam) (Entered: 08/29/2022) (1) |
